Clinical trial
Effects of Lysozyme On Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study
NCT01645800 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Lysozyme On Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- March 31, 2015
- Enrollment
- 408 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
copd